. 2016 Jan;25(167):16.

Postmenopausal hormone replacement therapy: ovarian cancer

No authors listed

No authors listed. Prescrire Int. 2016 Jan.

. 2016 Jan;25(167):16.

Abstract

About 1 additional ovarian cancer per 1000 women exposed to post- menopausal hormone replacement therapy for 5 years.

False alarm: postmenopausal hormone therapy and ovarian cancer.
Shapiro S. Shapiro S. Climacteric. 2007 Dec;10(6):466-9, discussion 469-70. doi: 10.1080/13697130701730539. Climacteric. 2007. PMID: 18049939
Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P. Lacey JV Jr, et al. J Natl Cancer Inst. 2006 Oct 4;98(19):1397-405. doi: 10.1093/jnci/djj375. J Natl Cancer Inst. 2006. PMID: 17018786
An analysis of ovarian cancer in the Million Women Study.
Neves-E-Castro M. Neves-E-Castro M. Gynecol Endocrinol. 2007 Jul;23(7):410-3. doi: 10.1080/09513590701483910. Gynecol Endocrinol. 2007. PMID: 17701773
Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
Neves-E-Castro M. Neves-E-Castro M. Clin Obstet Gynecol. 2008 Sep;51(3):607-17. doi: 10.1097/GRF.0b013e318180b988. Clin Obstet Gynecol. 2008. PMID: 18677154 Review.
Estrogen-progestogen replacement therapy and ovarian cancer: an update.
La Vecchia C. La Vecchia C. Eur J Cancer Prev. 2006 Dec;15(6):490-2. doi: 10.1097/01.cej.0000205026.14515.de. Eur J Cancer Prev. 2006. PMID: 17106327 Review.

A Simple Mathematical Model Demonstrates the Potential for Cell-Based Hormone Therapy to Address Dysregulation of the Hypothalamus-Pituitary-Ovary Axis in Females with Loss of Ovarian Function.
Duke RE, Stanich NJ, Sittadjody S, Opara EC, Berberich JA, Saul JM. Duke RE, et al. Ann Biomed Eng. 2024 Jul;52(7):1894-1907. doi: 10.1007/s10439-023-03307-w. Epub 2023 Jul 12. Ann Biomed Eng. 2024. PMID: 37436565 Free PMC article.